β2 Integrin-mediated Cell-Cell Contact Transfers Active Myeloperoxidase from Neutrophils to Endothelial Cells*

Background: How endothelial cells (ECs) could acquire exogenous neutrophil myeloperoxidase (MPO) is unknown. Results: ECs acquired enzymatically active MPO directly from neutrophils, via β2 integrin-mediated cell-cell contact independent of extracellular MPO release. Conclusion: Neutrophils directly transfer MPO to ECs by cell-cell contact. Significance: Direct delivery of MPO to ECs may contribute to the vascular pathology and dysfunction seen in atherosclerosis and vasculitides. Atherosclerosis and vasculitis both feature inflammation mediated by neutrophil-endothelial cell (EC) contact. Neutrophil myeloperoxidase (MPO) can disrupt normal EC function, although the mechanism(s) by which MPO is transferred to ECs are unknown. We tested the hypothesis that close, β2 integrin-dependent neutrophil-EC contact mediates MPO transfer from neutrophils to ECs. We used sensitive MPO assays and flow cytometry to detect MPO in ECs and demonstrate that ECs acquired MPO when contacted by neutrophils directly but not when ECs and neutrophils were separated in Transwells. The transfer was dependent on neutrophil number, exposure time, and incubation temperature. Transfer occurred in several EC types, increased with endotoxin, was not accompanied by MPO release into the medium, and was not abrogated by inhibiting degranulation to secretagogues. Confocal microscopy showed MPO internalization by ECs with cytoplasmic and nuclear staining. Neutrophils and ECs formed intimate contact sites demonstrated by electron microscopy. Blocking CD11b or CD18 β2 integrin chains, or using neutrophils from CD11b gene-deleted mice, reduced MPO transfer. EC-acquired MPO was enzymatically active, as demonstrated by its ability to oxidize the fluorescent probe aminophenyl fluorescein in the presence of a hydrogen peroxide source. The data suggest an alternative to EC uptake of soluble MPO, namely the cell contact-dependent, β2 integrin-mediated transfer from neutrophils. The findings could be of therapeutic relevance in atherosclerosis and vasculitis.

[1]  A. Kettle,et al.  Myeloperoxidase: a front‐line defender against phagocytosed microorganisms , 2013, Journal of leukocyte biology.

[2]  A. Kettle,et al.  Ceruloplasmin Is an Endogenous Inhibitor of Myeloperoxidase* , 2013, The Journal of Biological Chemistry.

[3]  J. Flemmig,et al.  The Fluorescein-derived Dye Aminophenyl Fluorescein Is a Suitable Tool to Detect Hypobromous Acid (HOBr)-producing Activity in Eosinophils* , 2012, The Journal of Biological Chemistry.

[4]  C. Meisinger,et al.  Myeloperoxidase is associated with incident coronary heart disease independently of traditional risk factors: results from the MONICA/KORA Augsburg study , 2012, Journal of internal medicine.

[5]  M. Rane,et al.  Granule Exocytosis Contributes to Priming and Activation of the Human Neutrophil Respiratory Burst , 2011, The Journal of Immunology.

[6]  M. Sperandio,et al.  Myeloperoxidase attracts neutrophils by physical forces. , 2011, Blood.

[7]  A. Kettle,et al.  Urate as a Physiological Substrate for Myeloperoxidase , 2011, The Journal of Biological Chemistry.

[8]  C. Lam,et al.  Prognostic value of plasma myeloperoxidase in ESRD patients. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  S. Hazen,et al.  Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation , 2010, Nature Medicine.

[10]  M. Gollasch,et al.  BK channels in innate immune functions of neutrophils and macrophages. , 2009, Blood.

[11]  W. Nauseef How human neutrophils kill and degrade microbes: an integrated view , 2007, Immunological reviews.

[12]  M. Glennie,et al.  Intimate Cell Conjugate Formation and Exchange of Membrane Lipids Precede Apoptosis Induction in Target Cells during Antibody-Dependent, Granulocyte-Mediated Cytotoxicity1 , 2007, The Journal of Immunology.

[13]  A. Schmaier,et al.  Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein-Kinin system. , 2007, The American journal of pathology.

[14]  M. Wellner,et al.  NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils. , 2007, Blood.

[15]  S. Hazen,et al.  Serum myeloperoxidase and mortality in maintenance hemodialysis patients. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  R. Leboeuf,et al.  Expression of Human Myeloperoxidase by Macrophages Promotes Atherosclerosis in Mice , 2005, Circulation.

[17]  Denise Lau,et al.  Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Remacle,et al.  Oxidation of low density lipoproteins by myeloperoxidase at the surface of endothelial cells: an additional mechanism to subendothelium oxidation. , 2004, Biochemical and biophysical research communications.

[19]  A. Chait,et al.  The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  E. Topol,et al.  Prognostic value of myeloperoxidase in patients with chest pain. , 2003, The New England journal of medicine.

[21]  A. Exley,et al.  Widespread coronary inflammation in unstable angina. , 2003, The New England journal of medicine.

[22]  F. Crea,et al.  Widespread coronary inflammation in unstable angina. , 2003, The New England journal of medicine.

[23]  P. Heeringa,et al.  Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. , 2002, The Journal of clinical investigation.

[24]  Chunxiang Zhang,et al.  Myeloperoxidase, a Leukocyte-Derived Vascular NO Oxidase , 2002, Science.

[25]  T. Mayadas,et al.  Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation. , 2001, Blood.

[26]  D. Boyle,et al.  Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors. , 1997, Journal of immunology.

[27]  B. Persson,et al.  Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin? , 1997, Clinical and experimental immunology.

[28]  L. Kjeldsen,et al.  Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. , 1995, Journal of immunology.

[29]  L. Kjeldsen,et al.  Control of exocytosis in early neutrophil activation. , 1993, Journal of immunology.

[30]  J. Loike,et al.  The Role of Protected Extracellular Compartments in Interactions between Leukocytes, and Platelets, and Fibrin/Fibrinogen Matrices a , 1992, Annals of the New York Academy of Sciences.

[31]  S. Weiss,et al.  Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor. , 1990, Science.

[32]  H. Baum,et al.  Inactivation of alpha‐1‐proteinase inhibitor in serum by stimulated human polymorphonuclear leucocytes. Evidence for a myeloperoxidase‐dependent mechanism , 1988, Cell biochemistry and function.

[33]  R. Senior,et al.  Proteolysis by neutrophils. Relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro. , 1982, The Journal of clinical investigation.

[34]  Y. Zotterman,et al.  Baroceptive Impulses in the Carotid Sinus and Their Relation to the Pressure Reflex , 1941 .